The Moffitt Cancer Center (MCC) Department of Pharmacy PGY-2 Oncology Pharmacy Practice Residency is a 12-month program developed to meet or exceed all practice standards established by the American Society of Health-Systems Pharmacists (ASHP). This specialized, ASHP accredited residency is designed to further develop the resident's clinical oncology skills. Specifically, the resident will be actively involved in managing the therapeutic decisions and clinical outcomes of cancer patients in an inter-disciplinary environment. Since the first resident completed training in 1990, our program has obtained approval and funding for three specialized oncology residency positions. Residents participate in all aspects of oncology pharmacy practice pertaining to clinical practice and outcomes, research, and education. The residency contains a minor administrative and drug information component to facilitate clinical and/or research opportunities.
It is essential for pharmacy graduates to obtain the specialized oncology knowledge base and clinical skills required to become competent in the pharmaceutical care of cancer patients. Pharmacy residencies serve as one of the best modalities for pharmacy graduates to obtain specialized skills by providing the opportunity to apply and integrate pharmaceutical care principles in the care of cancer patients under the close supervision of a preceptor. Our residency program is designed to instill a philosophy of practice that embraces the concept of pharmacists being responsible and accountable for pursuing optimal drug therapy outcomes in the provision of oncology pharmaceutical care.
QUALIFICATIONS OF SITE AND PRECEPTORS
The Moffitt Cancer Center was established and licensed in 1986 as an independent non-profit hospital located at and affiliated with the University of South Florida College of Medicine. MCC obtained NCI Designated Cancer Center status in 1997 and NCI Comprehensive Cancer Center status in March of 2001. The Department of Pharmacy has established teaching affiliations with the University of South Florida, the University of Florida, Nova Southeastern, Palm Beach Atlantic, Lake Erie College of Osteopathic Medicine, Florida A&M University, and several other out of state Colleges of Pharmacy. The majority of the preceptors have obtained post-graduate degrees with post-graduate residency and/or fellowship training. Many of our residency preceptors are Board Certified in Oncology Practice (BCOP), Board Certified Pharmacotherapy Specialists (BCPS), and Board Certified Nutrition Specialist (BCNS).
The residents will complete 9 months of required clinical rotations, 2 months of elective rotations, and one month of MCC pharmacy orientation. Required rotations include: Medical Oncology, Hematology, Blood and Marrow Transplantation, Ambulatory Care (4 months), Investigational Drug Services, Clinical Research, and Orientation. Elective rotations may include, but are not limited to Pain and Palliative Care, Nutrition Support, Administration, Pediatric Oncology (off site), Personalized Medicine/Genomics, Cellular therapy, Infectious Disease, and a variety of Ambulatory Care clinics.
Pre-requisites include an advanced pharmacy degree, completion of a pharmacy practice residency (PGY1) or comparable additional clinical experience. Applicants must be eligible for licensure in the state of Florida.
Additional Salary Information: FLAT STIPEND
Internal Number: PGY-2
About Moffitt Cancer Center
Moffitt Cancer Center (MCC) is a non profit National Cancer Institute Designated Comprehensive Cancer Center located in Tampa, Florida. HLMCC was established in 1986 and sees approximately 25,000 new patients annually, resulting in 290,000 clinic visits and an average daily inpatient census of 240. As an oncology health care facility, MCC has achieved exemplary reviews by all regulatory agencies, including the Joint Commission of American Hospital Organizations (JCAHO), the Florida Department of Pharmacy Regulation (DPR), American Nurses Credentialing Center (ANCC) Magnet designation, and the Drug Enforcement Agency (DEA). Moffitt Cancer Center is ranked on the US News and World Report Best Hospitals for Cancer, and has received this ranking for the last 20 years. Moffitt has research affiliations with the following national collaborative groups: National Cancer Institute (NCI), Southwest Cooperative Oncology Group (SWOG), Gynecologic Oncology Group (GOG), and Radiation Therapy Oncology Group (RTOG). The MCC Department of Pharmacy has supported pharmacy residency programs and training for almost 30 years in this large and diverse patient base.